Orionis Biosciences retweeted
Top Alliances Of 2023 - Vote for @OrionisBio / @genentech. Bringing precision drug design to battle cancer and other life threatening diseases 👏invivo.citeline.com/IV148673…
Orionis Biosciences retweeted
Congratulations to #TBCPartner @orionisbio who last week announced a partnership with @genentech to leverage its Allo-Glue™ platform for the discovery of small molecule monovalent glues. (1/3)
Orionis Biosciences retweeted
Very cool to see a second collaboration on Molecular Glue discovery with @OrionisBio, here with @roche @genentech. Niko and friends are creative scientists, terrific partners at the bench. Proud to see this platform expand its potential impact. orionisbio.com/2023/09/genen…
Orionis Biosciences retweeted
📢 More news from the #VIBspinoff community: @OrionisBio announces collaboration with @genentech to discover and develop molecular glue class medicines. Applications are possible in major disease areas such as #oncology and #neurodegeneration. 👇
vibbio.tech/46cicvS
Orionis Biosciences retweeted
More fireworks after 6 pm at #AACR23: #CICR townhall with 3 awesome talks about molecular glue degraders. Michael Rapé (@RapeLab), Riccardo Sabatini (@OrionisBio) & Mary Matyskiela (@neomorphinc). Chaired by Ben Ebert (@DFCI_ChemBio). Glueing everybody to their seats. @AACR #TPD
Orionis Biosciences retweeted
Novartis-partnered Orionis secures $55M to push cytokine program into clinic - More like this Pharm2Market.app/ | @OrionisBio @Novartis#immunotherapy #Financing #SeriesC #Research #Pipeline #immunoOncology #MolecularGlues #cytokine #Biotech endpts.com/novartis-partnere…
Orionis Biosciences retweeted
Novartis-partnered Orionis secures $55M to push cytokine program into clinic - More like this Pharm2Market.app/ | @OrionisBio @Novartis#immunotherapy #Financing #SeriesC #Research #Pipeline #immunoOncology #MolecularGlues #cytokine #Biotech endpts.com/novartis-partnere…
Orionis Biosciences retweeted
Today #TBCPartner @OrionisBio announced a new financing to advance their pipeline of highly selective and tunable therapeutics for #cancer & beyond.
We’re excited to collaborate w/ Orionis as they work towards an anticipated clinical trial launch in 2023.
orb.ink/pr1022
Orionis Biosciences retweeted
.@OrionisBio emerged from stealth Wednesday, partnering with @Novartis on small molecule discovery and unveiling its protein-small molecule interaction screening platform buff.ly/3atQ1vx
Orionis Biosciences retweeted
We’re combining our expertise in #drugdiscovery with Orionis Biosciences’ amazing tech to more efficiently detect & prioritize previously elusive drug targets genome-wide.
Orionis Biosciences retweeted
Novartis to collaborate with Orionis Biosciences to identify and prioritize elusive drug targets genome-wide. #drugdiscovery
Orionis Biosciences retweeted
Congratulations to our #client @OrionisBio for announcing their debut today with a major drug discovery collaboration with @Novartis. Read more here: https://xitter.cf/t.co/YSQHaV1z00
















